Mark Reynolds - Aug 11, 2021 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Role
CFO
Signature
/s/ Mark W. Reynolds
Stock symbol
GOVX
Transactions as of
Aug 11, 2021
Transactions value $
$0
Form type
4
Date filed
8/11/2021, 05:37 PM
Next filing
Dec 8, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOVX Stock Option (right to buy) Award $0 +128K $0.00 128K Aug 11, 2021 Common Stock 128K $2.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.
F2 Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.